Delivery Order SPE2DB22D2009-SPE2DB25FL9KA
- Not listed
- The Defense Logistics Agency (DLA) awarded a $26,109.77 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,303.18 on August 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $16,566.76 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 12, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,987.45 for DESCOVY 200-25 mg tablets (30 units), with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,354.64 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,745.07 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, awarded on August 22, 2025. The contract carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $30,806.33 delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of DESCOVY 200-25 mg tablets, with a completion date of June 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its Corporate Office location, leveraging its established role as a critical pharmaceutical distributor for federal military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) valued at $20,629.38 under a firm fixed-price contract. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform this delivery order from its corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,579.09 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) with a completion date of September 22, 2025. This competitive, non-set-aside contract reflects firm fixed pricing for pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected based on its...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FL9KADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,388.63 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units). This firm fixed-price delivery order, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, represents a non-competitive, non-set-aside award executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major pharmaceutical distribution hub serving federal medical procurement needs. This delivery order falls under AmerisourceBergen's $999.9 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, running through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling the delivery of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The award supports critical medical supply needs for the Defense Health Agency and other federal healthcare systems. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen regularly fulfills delivery orders under this IDC framework, demonstrating its capacity to meet urgent and ongoing military healthcare pharmaceutical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 5/27/25 |